|
1. González-González M, Díaz-Zepeda C, Eyzaguirre-Velásquez J, González-Arancibia C, Bravo JA, Julio-Pieper M. Investigating gut permeability in animal models of disease. Front Physiol. 2019;9:1962. 2. Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50(8):1-9. 3. Osanai M, Nishikiori N, Murata M, Chiba H, Kojima T, Sawada N. Cellular retinoic acid bioavailability determines epithelial integrity: Role of retinoic acid receptor α agonists in colitis. Mol Pharmacol. 2007;71(1):250-58. 4. Amit-Romach E, Uni Z, Cheled S, Berkovich Z, Reifen R. Bacterial population and innate immunity-related genes in rat gastrointestinal tract are altered by vitamin A-deficient diet. J Nutr Biochem. 2009;20(1):70-77. 5. Lima AA, Soares AM, Lima NL, Mota RM, Maciel BL, Kvalsund MP, Barrett LJ, et al. Vitamin A supplementation effects on intestinal barrier function, growth, total parasitic and specific Giardia spp. infections in Brazilian children: a prospective randomized, double-blind, placebo-controlled trial. J Pediatr Gastroenterol Nutr. 2010;50(3):309. 6. Li Y, Gao Y, Cui T, Yang T, Liu L, Li T, et al. Retinoic acid facilitates toll-like receptor 4 expression to improve intestinal barrier function through retinoic acid receptor beta. Cell Physiol Biochem. 2017;42(4):1390-406. 7. Xu C, Ooi WF, Qamra A, Tan J, Chua BY, Ho SW, et al. HNF4α pathway mapping identifies wild-type IDH1 as a targetable metabolic node in gastric cancer. Gut. 2020;69(2):231-42. 8. Shi Y, Zhou D, Wang B, Zhou D, Shi B. Roles and mechanisms of action of HNF‑4α in the hepatic differentiation of WB‑F344 cells. Int J Mol Med. 2019;43(2):1021-32. 9. Garrison WD, Battle MA, Yang C, Kaestner KH, Sladek FM, Duncan SA. Hepatocyte nuclear factor 4α is essential for embryonic development of the mouse colon. Gastroenterology. 2006;130(4):19-e1. 10. Darsigny M, Babeu JP, Dupuis AA, Furth EE, Seidman EG, Lévy É, et al. Loss of hepatocyte-nuclear-factor-4α affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PloS One. 2009;4(10):e7609. 11. Boyd M, Bressendorff S, Møller J, Olsen J, Troelsen JT. Mapping of HNF4α target genes in intestinal epithelial cells. BMC Gastroenterol. 2009;9(1):1-6. 12. Saad RS, Ghorab Z, Khalifa MA, Xu M. CDX2 as a marker for intestinal differentiation: Its utility and limitations. World J Gastrointest Surg. 2011;3(11):159. 13. Sambuy Y, De Angelis I, Ranaldi G, Scarino ML, Stammati A, Zucco F. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol. 2005;21(1):1-26. 14. Nalle SC, Turner JR. Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease. Mucosal Immunol. 2015;8(4):720-30. 15. Chang Q, Chen Z, You J, McNutt MA, Zhang T, Han Z, et al. All-trans-retinoic acid induces cell growth arrest in a human medulloblastoma cell line. J Neurooncol. 2007;84(3):263-67. 16. Das A, Banik NL, Ray SK. Molecular mechanisms of the combination of retinoid and interferon-gamma for inducing differentiation and increasing apoptosis in human glioblastoma T98G and U87MG cells. Neurochem Res. 2009;34(1):87-101. 17. Briviba K, Schnäbele K, Schwertle E, Blockhaus M, Rechkemmer G. β-Carotene inhibits growth of human colon carcinoma cells in vitro by induction of apoptosis. Biol Chem. 2001; 382(12):1663-68. 18. Li X, Madison BB, Zacharias W, Kolterud A, States D, Gumucio DL. Deconvoluting the intestine: molecular evidence for a major role of the mesenchyme in the modulation of signaling cross talk. Physiol Genomics. 2007;29(3):290-301. 19. Stegmann A, Hansen M, Wang Y, Larsen JB, Lund LR, Ritié L, et al. Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. Physiol Genomics. 2006;27(2):141-55. 20. Olsen L, Bressendorff S, Troelsen JT, Olsen J. Differentiation-dependent activation of the human intestinal alkaline phosphatase promoter by HNF-4 in intestinal cells. Am J Physiol Gastrointest Liver Physiol. 2005;289(2):G220-26. 21. Liu W, Hu D, Huo H, Zhang W, Adiliaghdam F, Morrison S, et al. Intestinal alkaline phosphatase regulates tight junction protein levels. J Am Coll Surg. 2016;222(6):1009-17. 22. Stevison F, Hogarth C, Tripathy S, Kent T, Isoherranen N. Inhibition of the all-trans retinoic acid (atRA) hydroxylases CYP26A1 and CYP26B1 results in dynamic, tissue-specific changes in endogenous atRA signaling. Drug Metab Dispos. 2017;45(7):846-54. 23. Grenier E, Maupas FS, Beaulieu J-F, Seidman E, Delvin E, Sane A, et al. Effect of retinoic acid on cell proliferation and differentiation as well as on lipid synthesis, lipoprotein secretion, and apolipoprotein biogenesis. Am J Physiol Gastrointest. 2007;293(6):G1178-G89. 24. Benahmed F, Gross I, Gaunt SJ, Beck F, Jehan F, Domon-Dell C, et al. Multiple regulatory regions control the complex expression pattern of the mouse Cdx2 homeobox gene. Gastroenterology. 2008;135(4):1238-47. e3. 25. Larsen S, Davidsen J, Dahlgaard K, Pedersen OB, Troelsen JTJIjoms. HNF4α and CDX2 regulate intestinal YAP1 promoter activity. Int J Mol Sci. 2019;20(12):2981. 26. Saandi T, Baraille F, Derbal-Wolfrom L, Cattin A, Benahmed F, Martin E, et al. Regulation of the tumor suppressor homeogene Cdx2 by HNF4α in intestinal cancer. Oncogene. 2013;32(32):3782-88. 27. Verzi MP, Shin H, San Roman AK, Liu XS, Shivdasani RAJM. Intestinal master transcription factor CDX2 controls chromatin access for partner transcription factor binding. Mol Cell Biol. 2013;33(2):281-92. 28. Girard R, Darsigny M, Jones C, Maloum-Rami F, Gélinas Y, Carpentier AC, et al. HNF4α is a novel regulator of intestinal glucose-dependent insulinotropic polypeptide. Sci Rep. 2019;9(1):1-11. 29. Zheng J, He S, Qi J, Wang X, Yu J, Wu Y, et al. Targeted CDX2 expression inhibits aggressive phenotypes of colon cancer cells in vitro and in vivo. Int J Oncol. 2017;51(2):478-88. 30. Park H-Y, Kunitake Y, Hirasaki N, Tanaka M, Matsui T. Theaflavins enhance intestinal barrier of Caco-2 Cell monolayers through the expression of AMP-activated protein kinase-mediated Occludin, Claudin-1, and ZO-1. Biosci Biotechnol Biochem. 2015;79(1):130-7.
|
